The China Precision Medicine Cloud: A world-leading platform to benefit patients and health
May 24, 2016
Huawei, WuXi AppTec and WuXi NextCODE launch the most powerful, proven and quality-certified national-scale cloud infrastructure for using the genome to improve medicine and health
· Will benefit patients by accelerating capabilities in discovery, clinical medicine and wellness
· The world’s leading genomics platform hosted on China’ssecure and reliablecloud network
· A unified infrastructure to serve the China Precision Medicine Initiative, genome discovery of unrivalled scale, as well as clinical diagnostics and drug development
SHENZHEN; SHANGHAI; CAMBRIDGE, Massachusetts;and REYKJAVIK, 24 May 2016 –Huawei, a leading global information and communications technology provider, and WuXiAppTec, the global open-access R&D platform, today launched the China Precision Medicine Cloud at a ceremony in Shanghai. This platform brings together three unique elements: Huawei’s industry-leading capabilities and national network for cloud computing; the globally recognized medical innovation expertise of WuXi AppTec; and the unrivalled competence of its subsidiary WuXi NextCODE in organizing, mining and sharing genomics big data.
The technology in this platform underpins data infrastructure across China and the largest and most advanced precision medicine projects around the world–from national genome projects to gene discovery, clinicaldiagnostics, targeted pharmaceutical development and scientific wellness. It will link scientific excellence and data from across Chinathrough a secure nationwide network and governmental, medical, academic and industry collaborations.
A unified cloud that enables both clinical and research genomics in real time, online is the foundation for delivering precision medicine efficiently at national scale. WuXi AppTec and Huawei will follow the guidance of the China Food and Drug Administration (CFDA) and work closely with partner life-science cloud providers to develop the data standards and exchange framework required to deliver the China PMI. WuXi AppTec and WuXi NextCODE solutions already meet US CAP and CLIA standards and include HIPAA-compliant DNAnexus technology delivering the precision FDA in the United States, so that in implementing guidelines developed by the CFDA the China Precision Medicine Cloud will be well positioned for global compliance and collaboration.
“It is an honor to have the opportunity to do our part in enabling doctors, scientists, companies and policymakers to develop and implement the most advanced precision medicine across China,” said Dr. Ge Li, Chairman and CEO of WuXi AppTec. “The China Precision Medicine Cloud aims to harness unique strengths to accelerate innovation. This collaboration is a direct extension of the WuXi commitment to services with high clinical impact, leveraging big data to create the one kind of value that matters: benefit for people and patients.”
“We are focused on unlocking the full potential of precision medicine in China,” said Hannes Smarason, COO of WuXi NextCODE. “This is a big data challenge, and what we are creating here is the fusion of the largest scale genomics platform and the leading China cloud network. It is a win-win for China Precision Medicine and its impact here and around the world.”
Huawei is a leading global information and communications technology (ICT) solutions provider. Our aim is to enrich life and improve efficiency through a better connected world, acting as a responsible corporate citizen, innovative enabler for the information society, and collaborative contributor to the industry. Driven by customer-centric innovation and open partnerships, Huawei has established an end-to-end ICT solutions portfolio that gives customers competitive advantages in telecom and enterprise networks, devices and cloud computing. Huawei's 170,000 employees worldwide are committed to creating maximum value for telecom operators, enterprises and consumers. Our innovative ICT solutions, products and services are used in more than 170 countries and regions, serving over one-third of the world's population. Founded in 1987, Huawei is a private company fully owned by its employees.
About WuXi AppTec
WuXi AppTec is a leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform company with global operations. As an innovation-driven and customer-focused company, WuXi AppTec provides a broad and integrated portfolio of services to help our worldwide customers and partners shorten the discovery and development time and lower the cost of drug and medical device R&D through cost-effective and efficient solutions. With its industry-leading capabilities in small molecule R&D and manufacturing, biologics R&D and manufacturing, cell therapy and gene therapy R&D and manufacturing, medical device testing, and molecular testing and genomics, WuXi platform is enabling more than 2,000 innovative collaborators from more than 30 countries to bring innovative healthcare products to patients, and to fulfill WuXi’s dream that “every drug can be made and every disease can be treated.”
About WuXi NextCODE
WuXi NextCODE is agenomic information company applying sequence data to deliver better health and precision medicine for people around the world. Our uniquely comprehensiveopen-access capabilities include CLIA- and CAP-certified sequencing; a novel database architecture that mines and manages more genomes than any other; the world’s leading genome interpretation and discovery system, available installed or in the cloud; a pioneering internet of DNA that enables users to query and collaborate using massive genomic datasets online with unrivalled resolution and efficiency; the know-how to apply genomics to optimize drug development; and a growing range of tests and scans to improve rare disease diagnosis, targeted cancer treatment, and wellness. With offices in Shanghai, Cambridge, Massachusetts and Reykjavik, we serve companies and health systems, clinicians and researchers, and people and populations worldwide.WuXi NextCODE is a subsidiary of WuXiAppTec.
+1 (781) 775 6206